Item 8.01Other Events.
On April 23, 2020, the Company announced that its Board has approved the postponement of the Company’s Annual Meeting, from June 5, 2020 to August 6, 2020. The time and location of the Annual Meeting will be set forth in the notice to shareholders.
Due to public health concerns regarding COVID-19 and government-recommended and required limits on gatherings and events, the Board has determined that it would be in the best interest of the shareholders to postpone the Annual Meeting. Helios’s first priority is to protect the health and safety of its stockholders, employees and the community. The Company will continue to monitor developments regarding COVID-19.
Because of the postponement of the Annual Meeting, the Company has reopened the period for the furnishing of shareholder proposals to be included in the 2020 Definitive Proxy Statement on Form DEF 14A (the “Proxy Statement”) under applicable SEC rules, and such period will now expire on May 4, 2020. The deadline for nominations under the Company’s bylaws is now May 4, 2020.
The Company’s shareholders of record as of the close of business on June 1, 2020 will be entitled to notice and to vote at the Annual Meeting.
Helios is relying on the SEC’s Order under Section 36 of the Securities Exchange Act of 1934, as amended, Granting Exemptions From Specified Provisions of the Exchange Act and Certain Rules Thereunder dated March 25, 2020 (Release No. 34-88465) (the “Order”) to delay the filing of its Proxy Statement, including the information omitted from the Company’s Annual Report on Form 10-K for the year ended December 28, 2019 pursuant to General Instruction G(3) of the Form 10-K (the “Part III Information”), which it expects to include in the Proxy Statement, due to the circumstances related to the COVID-19 pandemic. The Company is in the process of working on a remote basis to file the Proxy Statement, including the Part III Information, as quickly as possible. Notwithstanding the foregoing, the Company expects to file the Proxy Statement, including the Part III Information, no later than June 10, 2020 (which is 45 days from the Proxy Statement’s original filing deadline of April 26, 2020).
On April 23, 2020, Helios issued a press release in connection with foregoing. A copy of the press release is attached hereto as Exhibit 99.1 and incorporated herein by reference.
The Company is supplementing the risk factors previously disclosed in the Company’s Annual report on Form 10-K for the year ended December 28, 2019 with the following risk factor:
We face various risks related to health epidemics, pandemics and similar outbreaks, including the global outbreak of COVID-19.
In recent weeks, the continued spread of COVID-19 has led to disruption and volatility in various aspects of our business. It is possible that the continued spread of COVID-19 could cause disruption in our supply chain; cause delay, or limit the ability of customers to perform, including in making timely payments to us; impact investment performance; interrupt our employee’s ability to come to work, and cause other unpredictable events. We continue to work with our stakeholders (including customers, employees, suppliers and local communities) to address responsibly this global pandemic. We continue to monitor the situation, to assess further possible implications to our business, supply chain and customers, and to take actions in an effort to mitigate adverse consequences. We cannot at this time predict the impact of the COVID-19 pandemic, but it could have a material adverse effect on our business, financial position, results of operations and/or cash flows.
The Company will provide a statement of its financial results for the first quarter of 2020 when the Company issues its earnings release on May 4, 2020.